Cambridge-based Sphere Fluidics has introduced a new high-sensitivity assay designed for single-cell detection of Fc fusion proteins, potentially accelerating the development of this important class of biologic therapeutics. The technology leverages microfluidic capabilities to enable rapid screening of therapeutic protein-producing cell lines.
A new range of synthetic nanodiscs has been developed that facilitates the preparation of multi-pass transmembrane proteins in their active form, potentially advancing both fundamental membrane protein research and therapeutic development. The polymer-based platform addresses several long-standing challenges in membrane protein preparation and characterisation.
Two prominent European biospecimen and life sciences companies have combined to strengthen research capabilities across Europe and North America, marking significant expansion in biospecimen services and stem cell research sectors.
April 11 – 15, 2025 Vienna, Austria
February 3 – 6, 2025 Dubai, UAE
Association for Diagnostics and Laboratory Medicine (formerly AACC) July 27 – 31, 2025 – Chicago, USA
CAP25 September 13 – 16, 2025 – Orlando, USA
September 6 – 10, 2025
MEDICA – Düsseldorf, Germany 17 – 20 november 2025
A groundbreaking customizable immunoassay system developed by Japanese researchers offers rapid detection of disease biomarkers, allergens and other biomolecules with exceptional sensitivity, potentially revolutionising point-of-care diagnostics
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.